OVERVIEW

Addressing the Challenges of C difficile Infection (CDI) in IBD: Strategies for Effective Prevention and Treatment is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Dec 21, 2018 - Dec 21, 2019.

Accreditation:
CME
Physicians
Imedex designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 credits.
PAs should only claim credit commensurate with the extent of their participation.

CNE
This continuing nursing education activity awards 1.25 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.25 contact hours.

CPE
This knowledge-based activity (JA0006201-9999-18-246-H01-P) is approved for 1.25 contact hours (0.125 CEUs) of continuing pharmacy education.

Target Audience:
This activity is intended for IBD specialists, gastroenterologists, GI fellows, and other healthcare professionals (internists, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, etc) involved and/or interested in the therapeutic management of patients with IBD.

Overview:
Clostridium difficile infection (CDI) is a cause of morbidity and mortality in the United States, and the incidence and severity of CDI has increased in recent years. The CDC has designated C difficile as 1 of 3 pathogens considered to be lethal and CDI as an urgent antibiotic resistance threat. In patients with inflammatory bowel disease (IBD), CDI has a more progressive disease course and incurs higher morbidity and mortality, increased hospitalizations, and increased need for surgical intervention, resulting in clinical management challenges. Because the clinical presentations of CDI and IBD with colitis overlap to a large extent, diagnosis is challenging. It is difficult to differentiate an IBD flare from CDI symptoms, and this contributes to a delay in CDI treatment for many patients with IBD.

This webcast addresses clinical practice gaps related to: making a CDI diagnosis, optimal guideline-directed co-treatment of CDI and IBD, and managing recurrent CDI in IBD.

Objectives:
Upon successful completion of this educational activity, participants should be better able to:
• Employ guideline recommendations for the diagnosis of CDI in patients with IBD
• Outline the factors that contribute to the difficulty in treating CDI in patients with IBD
• Discuss therapeutic strategies to reduce the risk of recurrence of CDI in patients with IBD